Endocrinology

Top Story

Insulin resistance increases Alzheimer’s risk in middle-aged adults

July 27, 2015

Late middle-aged adults with insulin resistance may be at greater risk for developing Alzheimer’s disease, according to research in JAMA Neurology.

In a population-based, cross-sectional study of middle-aged adults with and without a parental history of Alzheimer’s disease, researchers conducting imaging analysis found that adults with higher insulin resistance also had lower glucose metabolism in the brain’s lower left medial temporal lobe, which researchers found was related to memory function.

In the Journals

CV risk similar for second-line diabetes drugs plus metformin

July 27, 2015
Adults with type 2 diabetes using metformin combined with insulin have a similar cardiovascular risk when compared with adults using metformin combined with…
In the Journals

Rates of diabetic ketoacidosis low with Invokana therapy

July 27, 2015
Diabetic ketoacidosis occurred with low frequency in patients treated with Invokana, according to recent study findings published in Diabetes Care. “On May 15…
In the Journals

Reporting of serious AEs to FDA often delayed by drug companies

July 27, 2015
Nearly 10% of adverse events are not reported to the FDA within the 15-day period drug companies have to disclose the events, according to recently published data…
High liver fat is associated with increased risk of metabolic syndrome In the Journals

High liver fat is associated with increased risk of metabolic syndrome

July 27, 2015
High liver fat content was found to be associated with metabolic syndrome in patients with nonalcoholic fatty liver disease, independent of nonalcoholic steatohepatitis…
More News Headlines »
Obesity Consults

Obesity Consults: Volume 2, Number 5
Practical Guide to Medications Approved for Chronic Weight Management

Several pharmacologic options for the management of obesity have been approved by the US FDA, giving clinicians a range…
More »
Meeting News Coverage Video
VIDEO: War on diabetes continues since founding in 1940

VIDEO: War on diabetes continues since founding in 1940

June 12, 2015
BOSTON — Samuel Dagogo-Jack, MD, discusses the war on diabetes declared in 1940 after an alarming 750,000…
More »
CME
Real-world Use of Anti-VEGF Therapy

Real-world Use of Anti-VEGF Therapy

This activity is supported by an educational grant from Genentech, Inc.

Anti-VEGF is well established as first-line therapy for the treatment of diabetic macular edema (DME) and age-related…
More »
Current Issues
View the Current Issues
morganatic-roan
morganatic-roan